Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

LNX3 Activators

The class of chemicals known as LNX3 Activators consists of compounds that can influence the activity of LNX3 indirectly, primarily through the inhibition of proteasome activity or autophagy. Activators of this class are part of proteasome inhibitors that disrupt the degradation of ubiquitinated proteins. This action can result in an upregulation of E3 ubiquitin-protein ligases like LNX3, as the cell attempts to increase protein degradation to compensate for the inhibited proteasome activity.

In parallel, the modulation of autophagy also plays a role in the activation of LNX3. The second group of activators of this class, autophagy inhibitors, disrupt the process of autophagy, a cellular mechanism for degrading and recycling cellular components. Autophagy is closely linked with the ubiquitin-proteasome system (UPS), the primary pathway for protein degradation in cells, wherein LNX3 operates. When autophagy is inhibited, the cell relies more heavily on the UPS, potentially increasing the activity of E3 ubiquitin-protein ligases like LNX3. Furthermore, activators of this class can also disrupt the ubiquitination cascade at various points, potentially affecting the activity of E3 ubiquitin-protein ligases like LNX3. Inhibition of these enzymes can disrupt the balance of protein homeostasis, leading to an increase in the activity of E3 ubiquitin-protein ligases as the cell attempts to restore balance.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor. It prevents the degradation of ubiquitinated proteins, which can indirectly lead to an increase in the activity of E3 ubiquitin-protein ligases like LNX3.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is another proteasome inhibitor. It prevents the degradation of ubiquitinated proteins, indirectly leading to an increase in the activity of E3 ubiquitin-protein ligases such as LNX3.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a proteasome inhibitor. By preventing the degradation of ubiquitinated proteins, it can indirectly increase the activity of E3 ubiquitin-protein ligases like LNX3.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is a proteasome inhibitor. It prevents the degradation of ubiquitinated proteins, potentially leading to an increase in the activity of E3 ubiquitin-protein ligases like LNX3.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

MLN4924 is a NEDD8-activating enzyme inhibitor. It disrupts the neddylation pathway, which controls the activity of cullin-RING E3 ligases, potentially affecting the activity of E3 ubiquitin-protein ligases like LNX3.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

PYR-41 is an E1 ubiquitin-activating enzyme inhibitor. It inhibits the initial step of the ubiquitination cascade, potentially influencing the activity of E3 ubiquitin-protein ligases like LNX3.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine is an autophagy inhibitor. By inhibiting autophagy, it can potentially affect the activity of E3 ubiquitin-protein ligases like LNX3.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor and autophagy inducer. By modulating autophagy, it can potentially affect the activity of E3 ubiquitin-protein ligases like LNX3.

hydroxychloroquine

118-42-3sc-507426
5 g
$57.00
1
(0)

Hydroxychloroquine is an autophagy inhibitor. By inhibiting autophagy, it can potentially affect the activity of E3 ubiquitin-protein ligases like LNX3.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

3-Methyladenine is an autophagy inhibitor. By inhibiting autophagy, it can potentially affect the activity of E3 ubiquitin-protein ligases like LNX3.